CSPC Innovation Pharmaceutical Co Ltd Class A (SHE:300765) — Market Cap & Net Worth
Market Cap & Net Worth: CSPC Innovation Pharmaceutical Co Ltd Class A (300765)
CSPC Innovation Pharmaceutical Co Ltd Class A (SHE:300765) has a market capitalization of $6.24 Billion (CN¥42.66 Billion) as of May 3, 2026. Listed on the SHE stock exchange, this China-based company holds position #3095 globally and #436 in its home market, demonstrating a -5.21% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CSPC Innovation Pharmaceutical Co Ltd Class A's stock price CN¥30.37 by its total outstanding shares 1404592944 (1.40 Billion). Analyse how efficiently does CSPC Innovation Pharmaceutical Co Ltd Cl generate cash to see how efficiently the company converts income to cash.
CSPC Innovation Pharmaceutical Co Ltd Class A Market Cap History: 2019 to 2026
CSPC Innovation Pharmaceutical Co Ltd Class A's market capitalization history from 2019 to 2026. Data shows growth from $1.19 Billion to $6.24 Billion (26.53% CAGR).
Index Memberships
CSPC Innovation Pharmaceutical Co Ltd Class A is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ChiNext
CNT
|
$1.31 Trillion | 0.47% | #43 of 100 |
Weight: CSPC Innovation Pharmaceutical Co Ltd Class A's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CSPC Innovation Pharmaceutical Co Ltd Class A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CSPC Innovation Pharmaceutical Co Ltd Class A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.45x
CSPC Innovation Pharmaceutical Co Ltd Class A's market cap is 3.45 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.19 Billion | $1.26 Billion | $273.20 Million | 0.94x | 4.34x |
| 2020 | $1.31 Billion | $1.32 Billion | $299.84 Million | 0.99x | 4.37x |
| 2021 | $1.41 Billion | $1.85 Billion | $393.23 Million | 0.76x | 3.57x |
| 2022 | $1.47 Billion | $2.63 Billion | $726.28 Million | 0.56x | 2.02x |
| 2023 | $6.21 Billion | $2.54 Billion | $434.44 Million | 2.45x | 14.29x |
| 2024 | $5.47 Billion | $1.98 Billion | $53.73 Million | 2.76x | 101.72x |
| 2025 | $7.41 Billion | $2.15 Billion | -$241.13 Million | 3.45x | N/A |
Competitor Companies of 300765 by Market Capitalization
Companies near CSPC Innovation Pharmaceutical Co Ltd Class A in the global market cap rankings as of May 3, 2026.
Key companies related to CSPC Innovation Pharmaceutical Co Ltd Class A by market ranking:
- Nestlé S.A (F:NESM): Ranked #84 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #98 globally with a market cap of $203.05 Billion USD ( CHF160.61 Billion CHF).
- Danone SA (PA:BN): Ranked #527 globally with a market cap of $50.25 Billion USD ( €42.98 Billion EUR).
- Danone SA (F:BSND): Ranked #622 globally with a market cap of $42.57 Billion USD ( €36.41 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Nestlé S.A | F:NESM | $224.33 Billion | €85.60 |
| #98 | Nestle S.A. | SW:NESN | $203.05 Billion | CHF79.05 |
| #527 | Danone SA | PA:BN | $50.25 Billion | €66.74 |
| #622 | Danone SA | F:BSND | $42.57 Billion | €12.70 |
CSPC Innovation Pharmaceutical Co Ltd Class A Historical Marketcap From 2019 to 2026
Between 2019 and today, CSPC Innovation Pharmaceutical Co Ltd Class A's market cap moved from $1.19 Billion to $ 6.24 Billion, with a yearly change of 26.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥6.24 Billion | -15.80% |
| 2025 | CN¥7.41 Billion | +35.65% |
| 2024 | CN¥5.47 Billion | -11.99% |
| 2023 | CN¥6.21 Billion | +323.71% |
| 2022 | CN¥1.47 Billion | +4.25% |
| 2021 | CN¥1.41 Billion | +7.30% |
| 2020 | CN¥1.31 Billion | +10.46% |
| 2019 | CN¥1.19 Billion | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of CSPC Innovation Pharmaceutical Co Ltd Class A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.24 Billion USD |
| MoneyControl | $6.24 Billion USD |
| MarketWatch | $6.24 Billion USD |
| marketcap.company | $6.24 Billion USD |
| Reuters | $6.24 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CSPC Innovation Pharmaceutical Co Ltd Class A
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. The company offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, and doxofylline; and health food product… Read more